Feedback / Questions
Zantrene (bisantrene) - Race Oncology
https://www.proactiveinvestors.com.au/companies/news/1073241/race-oncology-doses-first-patient-in-trial-of-rc220-doxorubicin-for-solid-tumours-1073241.html
Jun 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next